Regulatory Storm for Jagsonpal Pharmaceuticals: Customs Order and FDA Warning Letter

Unknown Apr 02, 2026 850 Views

Jagsonpal Pharmaceuticals Limited has been issued a customs order confirming a differential duty of ₹51 million plus a penalty. This development follows recent regulatory challenges faced by the company, including a warning letter from the U.S. FDA regarding significant manufacturing lapses at it...